Shareholders have rejected Florenz’s takeover offer, and Bougen is still talking of putting a recapitalisation plan before the board.
Bevilles valued at $45 million in deal.
Outgoing chair says potential float of funds management arm something for future boards to consider.
Piping installed in thousands of Western Australian homes is implicated in leaks causing damage.
Crown gives green light to noted infrastructure investor.
Kiwi company appoints US distributor to help scale up sales.
It would be better to sell the 46% Kupe stake for nothing than keep it, says Forbar report.
Pharmacy group’s third-largest shareholder increased stake ahead of $40m special dividend announcement.
The company has got its head around the extent of the damage.
Rising interest rates put property syndicates under pressure on debt covenants.